Background: Tendon injuries are common problems among athletes. Complete recovery of the mechanical structure and function of ruptured tendons is challenging. It has been demonstrated that upregulation of glycolysis and lactate production occurs in wounds, inflammation sites, and cancerous tumors, and these metabolic changes also control growth and differentiation of stem and progenitor cells. Similar metabolic changes have been reported in human healing tendons. In addition, lactate production has increased in progenitors isolated from injured tendons after treatment with IL-1b. It is thought that the metabolic changes play a role in tendon healing after injury.
cell-based therapies, physical therapy, and other treatment modalities to augment tendon healing. 32, 39, 44 Current treatment strategies on tendon injuries remain moderately effective. 14, 32, 39 Tendon-healing strategies that result in consistently reproducible painless return to full preinjury function remain a challenge for clinicians.
Metabolic disorders such as diabetes mellitus and obesity are frequently associated with chronic tendinopathy and may have a negative effect on tendon repair. [1] [2] [3] [4] 8, 35 High plasma glucose levels in diabetes are considered a risk factor for tendinopathy. 25 This suggests a possibility that glucose metabolism is closely linked to tendon homeostasis and healing capacity. Indeed, previous studies showed that metabolites of glycolysis and lactate are elevated in healing human Achilles tendons. 16 In a case study, glucose uptake increased acutely after Achilles tendon surgery and remained high 3 months after surgery. 28 Tendons and neighboring tissues contain tendon stem/progenitor cells that may contribute to injury repair. 21, 27 These cells were reported in uninjured tendons in rodents, 6, 36 rabbits, 48 horses, 26 and humans 47 and observed in the repair process of overuse-induced minor tendon tears. 46 High glucose levels upregulate proteases in tendon cells and inhibit tenogenic differentiation in tendonderived stem cells in vitro and in tendon explants. 23, 24 IL1b, which is upregulated at the tendon injury site, 38 inhibits tenogenic differentiation of these injured-tendon derived progenitors and increases their lactate synthesis, while inhibition of lactate synthesis competes against the IL-1b action on tenogenic differentiation. 50 The purpose of this study was to investigate the biological and mechanical relationships between glucose metabolism (glycolysis) and lactate synthesis and tendon health with a murine model. We hypothesized that glycolysis and lactate synthesis increase in response to tendon injury and that the pharmacologic modulation of lactate synthesis is beneficial for tendon repair. We analyzed glucose metabolism with [U- 13 C]glucose and metabolomics analysis in injured mouse tendons and examined the effects of dichloroacetate (DCA), an indirect inhibitor of lactate production, on recovery of collagen fiber formation, mucoid degeneration, and biomechanical properties.
METHODS
All animal experiment procedures were approved by the Institutional Animal Care and Use Committee of the Children's Hospital of Philadelphia and University of Maryland, Baltimore.
Tendon Surgery
A total of 62 C57BL/6J female mice, aged 7 to 8 weeks, were used in this study. Animals were randomly selected to receive a surgically induced acute rupture of the Achilles tendon (n = 54 animals) or sham surgery (skin incision, n = 8) (see Appendix Figure A1 , available in the online version of this article). Specifically, a complete transverse incision was made at the midpoint of the right Achilles tendon, and the gap was left open before wound closure. 5 Animals were returned to cage activity and euthanized at 1 (n = 8), 4 (n = 44), or 10 (n = 10) weeks after surgery. Harvested tendons were subjected to metabolomics, histological, and biomechanical analyses.
DCA Administration
DCA (sodium DCA; Millipore Sigma) was dissolved in saline and intraperitoneally given to C57BL/6J mice: daily injections (100 mg/kg, 100 mL/mouse) from 1 day to 4 weeks after surgery. The same volume of saline as DCA solution was given to the control mice.
C-glucose Labeling Study
[U- 13 C]glucose (D-Glucose-13 C 6 , 400 mg/kg; Millipore Sigma) was peritoneally injected 1 hour before euthanasia. At the endpoint shown in Appendix Figure A1 , part A (available online), the uninjured or injured tendons covering neoforming tissue in midsubstance (n = 4/group) were snap-frozen in liquid nitrogen and subsequently ground to powder for perchloric acid extraction. A neutralized perchloric acid extract was prepared and used for measurement of glycolysis and metabolomics analysis.
GC-MS and LC-MS Methodology
For measurement of the 13 C enrichment, samples were prepared as described previously. 22,30,31 13 C enrichment in glucose, glyceraldehyde-3P (GA3P), and ribose-5P was determined with LC-MS (liquid chromatography-mass spectrometry) in multiple reaction-monitoring mode. 22 For glucose, we measured ion pairs 511-175, 512-175, 513-175, 514-175, 515-175, 516-175, and 517-175 for determination of M0, M1, M2, M3, M4, M5, and M6, respectively (containing 1-6 13 C atoms above natural abundance). For GA3P, we measured ion pairs at 501-175, 502-175, 503-175, and 504-175 for determination of M0, M1, M2, and M3, respectively (containing 1-3 13 C atoms above M0, the natural abundance). For ribose-5P, we measured ion pairs 561-175, 562-175, 563-175, 564-175, 565-175, and 566-175 for determination of M0, M1, M2, M3, M4, and M5, respectively (containing 1-5 13 C atoms above natural abundance). We used GC-MS (gas chromatography-mass spectrometry) for determination of 13 C enrichment in organic or amino acids as described. 30, 31 Isotopic enrichment for 13 C-lactate isotopomers was monitored at m/z 261, 262, 263, and 264 for M0, M1, M2, or M3, respectively (containing 1-3 13 C atoms above M0, the natural abundance). Isotopic enrichment in 13 13 C atoms above the natural abundance).
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C enrichment in glucose-derived metabolites and intermediates was expressed as molar percentage enrichment (M%E), which is the molar fraction percentage of analyte containing 13 C atoms above natural abundance. 30, 31 The M%E of an individual 13 C-labeled mass isotopomer was calculated as reported previously, 30, 31 and the amount in the tendons of 13 C-labeled mass isotopomer was calculated by the product of M%E/100 multiplied by the concentration (nmol/mg of protein) and was expressed as nanomole (nmol) of 
Histologic, Histochemical, and Immunohistochemical Analyses
Distal half hindlimbs were dissected and fixed with 4% (v/v) paraformaldehyde, decalcified with EDTA solution for 2 to 3 weeks, and embedded in paraffin. Longitudinal sections of the Achilles tendons (n = 4/group) (Appendix Figure A1 , part B, available online) were prepared and subjected to histologic staining with hematoxylin and eosin or alcian blue (pH 1.0). Ten to 15 paraffin section slides (3 or 4 sections/slide) covering the middle portion of injured tendons were obtained, and 2 or 3 slides (4 or 5 sections in total) were chosen and analyzed to evenly inspect the entirety of the injured tendons. Glycosaminoglycan accumulation was quantified by measuring alcian blue-positive area with the Hybrid Cell Count program in the BZ-X Analyzer (Keyence). Collagen fiber alignment was quantitatively evaluated by polarized light image analysis with custom Matlab software (Mathworks).
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For detection of lactate dehydrogenase A (LDHA) and lactate transporter (MCT1 and MCT4) expression, the sections were treated with sodium citrate buffer (pH 6.0) for 10 minutes at 95°C and blocked with 10% goat serum in phosphate-buffered solution (PBS). Endogenous avidin/ biotin was quenched with the Avidin/Biotin Blocking Kit (Vector Laboratories), followed by overnight incubation with rabbit anti-LDHA antibody (1:250; Cell Signaling Technology) or rabbit anti-MCT1 or anti-MCT4 antibodies (1:1000, generated by author N.J.P.) at 4°C. After washes with PBS, the sections were incubated with goat anti-rabbit biotinylated secondary antibody (1:200, Vector Laboratories) at room temperature for an hour and with ABC reagent (Vector Laboratories) for an hour, followed by visualization of the antibody with the ImmPACT DAB kit (Vector Laboratories) and counterstaining with hematoxylin. The results of immunostaining (n = 3 or 4/group) were evaluated by semiquantification of the images (score, 0-4; 4 is maximum), captured by the SPOT digital microscope camera with SPOT Imaging Software (Meyer Instruments, Inc).
Mechanical Testing and Collagen Alignment Measurement
The distal hindlimbs were dissected from the mice treated with DCA or vehicle (n = 10/group) 4 weeks after surgery (Appendix Figure A1 , part C, available online) and stored at 230°C until the analysis. Before mechanical testing, Achilles tendons with calcanei were fine dissected such that all musculature and surrounding soft tissue were removed. Specimens were hydrated in PBS immediately after dissection and throughout the course of mechanical testing. Tendon cross-sectional area was calculated with a custom laser-based device. 12 Mechanical testing was performed in an Instron 5542 test frame (Instron), and tendons were held in place with a custom fixture that gripped the calcaneus and tendon ends to a gauge length of 5 mm. Specimens underwent a previously described protocol consisting of preconditioning, stress-relaxation, and ramp to tensile failure at a rate of 0.1%/s. 9 Grayscale images were captured during mechanical testing, and fiber alignment was subsequently quantified with a cross-polarized light protocol, according to previously published methods. 19 
Micro-Computed Tomography Analyses
The distal hindlimbs were dissected from the mice treated with DCA or vehicle (n = 5/group) 10 weeks after surgery (Appendix Figure A1 , part C, available online), fixed with 10% neutralized formalin at 4°C, and subjected to microcomputed tomography analysis with a CT40 scanner (Scanco USA, Inc) at 55 kV and 70 mA. Data were analyzed at threshold 244 for detection of ectopically mineralized components.
Statistics
Student t tests or 2-way factorial analysis of variance, followed by Bonferroni post hoc multiple comparison tests, was used to identify differences between groups. Significance for tests was set as P \ .05 or P \ .01.
RESULTS

Injury-Induced Changes in Glucose Metabolism in Tendons
In the first set of experiments, we performed 13 C-metabolic analysis to examine alterations in glucose metabolism in tendons in response to injury. [U- 13 C]glucose was injected 1 hour before collection of the tendons at 1 or 4 weeks after surgery. We determined the relative percentage of [U- 13 C]glucose in the tendons, as well as the 13 C enrichment (M%E) of metabolites in the glycolysis pathway (eg, GA3P) and the pentose phosphate pathway (ribose-5P). We also analyzed the 13 C enrichement (M%E) of lactate, intermediates of the tricarboxylic acid (TCA) cycle, and amino acids. The isotopomers that we show in Figures 1  and 2 were the direct metabolites from [U- 13 C]glucose in the glycolysis pathway. There was no difference in 13 Clabeled glucose (M%E) in injured versus normal tendons ( Figure 1B) , suggesting a similar uptake of the injected [U-
13 C]glucose. However, the M%E of M3 isotopomer of 13 C-labeled GA3P ( Figure 1C ) and M5
13 C-labeled ribose-5P ( Figure 1D ) increased at 1 week after surgery with only a little difference at 4 weeks as compared with the uninjured tendons, suggesting that injured tendons greatly altered glucose metabolism by increasing the Figure 1 . The effect of injured tendons on glycolysis with or without treatment with dichloroacetate (DCA). Injured Achilles tendons were harvested 1 week (1W) or 4 weeks (4W) after the Achilles injury surgery. [U- 13 C]glucose (D-Glucose-13 C 6 , 400 mg/kg) was peritoneally injected 1 hour before euthanasia without or with DCA treatment (100 mg/kg, daily intraperitoneal injections). The extracts from uninjured or injured tendons (n = 4) were used for measurement of 13 C enrichment (M%E) in (B) 13 C-labeled glucose or metabolites: (C) GA-3P, (D) ribose-5P, (E) lactate, or (F) alanine-the metabolism of which is shown in panel A. Values are presented as mean 6 1 SD. *P \ .05. M%E, molar percentage enrichment.
relative pentose phosphate pathway and overall glycolysis. The stimulation of glycolysis by the injured tendons is further demonstrated by a significantly increased enrichment of M3 isotopomers (M%E) of 13 C-labeled lactate ( Figure  1E) . Similarly, the synthesis of M3 13 C-alanine was significantly higher at 1 and 4 weeks after injury ( Figure 1F ). 13 C-labeled lactate and alanine are both products derived from [U- 13 C]glucose through pyruvate ( Figure 1A ). Of interest is the observation that the augmentation of 13 Clabeled lactate and alanine production was similar at 1 and 4 weeks after injury, suggesting a persistent stimulation of glycolysis even 4 weeks after injury. The product concentrations of 13 C-labeled lactate and alanine were also calculated. The results are similar to those of 13 C enrichment (Appendix Figure A2 , available online).
Notwithstanding a high rate of glycolysis during the first 4 weeks after injury, flux through the TCA cycle was also significantly increased after 1 week and tended to return to normal range after 4 weeks of injury. This conclusion is supported by the generation of M2 13 C-labeled citrate (Figure 2B ) and M2 13 C-labeled glutamate ( Figure 2D ). M2 glutamate isotopomers, a marker of the flux through the TCA cycle, 30, 31 is generated from M2 13 C-labeled a-ketoglutarate via the glutamate dehydrogenase pathway (Figure 2A ). The production of M2 13 C-aspartate was significantly increased at 1 and 4 weeks after injury ( Figure 2D ). While 13 C aspartate is generated from 13 C-labeled oxaloacetate via transamination, 13 C-labeled oxaloacetate may be produced from pyruvate via pyruvate carboxylase and/or from malate via malate dehydrogenase. 30, 31 The persistent generation of 13 C-labeled aspartate in the injured tendon is parallel to generation of 13 C-labeled lactate and alanine at 1 and 4 weeks after injury (Figure 1, E and F) , suggesting that similar to lactate and alanine, the 13 C-labeled aspartate is mainly formed from pyruvate via the pyruvate carboxylase pathway. The product concentrations of 13 C-labeled citrate, glutamate, and aspartate were also increased in tendons after injury (Appendix Figure A2, available online) .
The results of the metabolomics analysis suggest that the injured tendons are high in the lactate synthesis from pyruvate. This was supported by the immunohistochemical examination for LDHA and lactate transporters ( were clearly detected at 1 week after surgery in the injured site, which were rich in fibroblastic cells and vessels (Figure 3I) , while the uninjured tendons showed marginal positive staining with these molecules (Figure 3, B-D) . At 4 weeks after injury, the staining of these molecules became weak but were still detected in the chondroid lesion at the edge of the injured tendons (Figure 3 , M-P, circled with dotted lines) where ectopic calcification is induced at later stages. Expression of MCT1 and MCT4 was found in the 
Effects of DCA Treatment on Tendon Healing
To examine the effect of augmented lactate synthesis on the healing process of the injured tendon, we treated the mice with DCA after tendon injury surgery. The data showed that the generation of 13 C-lactate was significantly reduced by DCA treatment at 1 and 4 weeks after surgery ( Figure 1E ; Appendix Figure A2 , part A, available online), indicating that DCA treatment inhibited lactate formation. However, DCA had little or no effect on the flux through the TCA cycle or the generation of 13 C-aspartate or glutamate ( Figure 2, C and D) . The body weight and body length were not significantly affected by DCA treatment (Appendix Figure A4 , available online).
Mechanical testing assays yielded significant differences between groups at the 4-week time point. The DCAtreated samples had thinner widths (confirmed with MCT4. The images were taken at the edges (stubs) and midsubstance of tendons. Strong immunoreactivity of LDHA, MCT1, and MCT4 in (E-L) 1 week-injured tendons remained in (M-P, circles) chondroid lesions at edges and (Q-T, circles) the region with high cell density at midsubstance 4 weeks after injury. Scale bar, 100 mm. histology) and smaller cross-sectional areas (Figure 4 , A and B) as compared with the control group. Modulus, maximum strength, and maximum force were significantly higher in the DCA-treated tendons than the vehicle-treated tendons (Figure 4 , C-E). Collagen fiber alignment was improved in the DCA-treated tendons, as they had lower values of circular standard deviation than the control tendons when measured during mechanical testing ( Figure  5A ) and with polarized light microscopy ( Figure 5B ).
In this Achilles tendon surgery model, the injured tendons induced chondroid degeneration and ectopic calcification. 5, 49 The DCA treatment reduced accumulation of mucopolysaccharides visualized by alcian blue staining ( Figure 5 , C and D) and the volume of mineralized masses ( Figure 5, E and F) .
DISCUSSION
The results indicate that tendons acutely change glucose metabolism with an increase in glycolysis and lactate synthesis in response to injury. We also demonstrated that treatment with an inhibitor of lactate synthesis stimulated recovery of biomechanical properties in injured tendons, improved collagen fiber alignment, and inhibited mucoid accumulation and ectopic calcification. The findings indicate that tendons alter glucose metabolism in response to injury and that the metabolic change can be targeted by metabolic modifiers for improvement of tendon healing. Our conclusion should be limited to the early phase of tendon healing in mice. The efficacy of DCA needs to be verified for the late phase of the tendon-healing process in mice and for other animal models. The effectiveness of DCA on human tendons remains to be clarified. However, the results in this study are consistent with and complemented by studies of human tendons showing that early-healing Achilles tendons contain higher levels of pyruvate and lactate, metabolites of glycolysis. 16 Altered glucose metabolism has been described under various pathologic conditions. In tumors, increases in glycolysis and lactate production under the aerobic condition, called the Warburg effect, have been found and extensively Figure 4 . The results from mechanical testing assays. (A) The width of the injured tendons (n = 10) was measured with histology and ImageJ, and (B) the cross-sectional area was determined with a laser-based system; there were significant decreases in the dichloroacetate (DCA) group for both. The DCA group also exhibited significant increases in (C) modulus, (D) maximum stress, and (E) maximum force. Scale bar is 250 mm for panel A. Values are presented as mean 6 1 SD. studied to understand the underlying cellular and molecular mechanisms and develop pharmacologic therapies for this condition. 10, 13 Upregulation of glycolysis and lactate synthesis has also been observed in the milieu of wounds and inflammation. 7, 15, 40 It is also critical for growth and survival of cancerous tumors and polarizing of macrophages. 10, 17, 34 Substantial evidence demonstrates that these metabolic changes control growth and differentiation of stem and progenitor cells. 29, 42 Greve et al 16 examined metabolic activity of human Achilles tendons at 2 weeks after surgery by measuring glucose and metabolites. The results demonstrated elevation of the contents of lactate, pyruvate, and glutamate in the healing tendons and further enhancement of their production by adjuvant intermittent pneumatic compression. 16 Consistent with this fundamental study, our metabolomics results revealed that glycolysis and lactate synthesis are stimulated in injured mouse tendons, as characterized by increases in 13 C enrichment of metabolites and intermediates, flux through glycolysis, and lactate synthesis in the metabolomics analysis with [U-
13 C]glucose. These changes were detected not only at the inflammation phase at 1 week after surgery but also at the early repair phase 4 weeks after surgery, indicating that cells responsible for suggests that the lactate metabolic activity was very high in the entirety of injured tendons at the initial phase and became lower but still high in the chondroid lesion and the region with a high density of fibrous cells.
DCA is an inhibitor of pyruvate dehydrogenase kinase (PDK) that inhibits pyruvate dehydrogenase. 43 Thus, DCA is thought to stimulate formation of pyruvate to acetylCoA and, thereby, the TCA cycle pathway and to indirectly inhibit lactate synthesis. The results of the metabolomics analysis confirmed that DCA treatment reduced lactate formation at 1 and 4 weeks after surgery. However, DCA treatment hardly affected the flux through the TCA cycle or the generation of 13 C-aspartate or glutamate. Although decarboxylation of pyruvate was enhanced and, thereby, lactate synthesis inhibited, the flux of intermediates and amino acids via the TCA cycle was not affected. The concentration of DCA that we used in this study could be not high enough to stimulate the TCA cycle activity. Further studies are required for understanding the pharmacologic action of DCA on inhibition of lactate production.
DCA treatment gave a strong beneficial effect on recovery of structure and biomechanical properties of injured tendons, at least in female mice. The results indicate that lactate production is critical for tendon healing. In wounds, lactate accumulates regardless of oxygen concentration and stimulates VEGF in macrophages and collagen synthesis in fibroblasts. 40 Therefore, lactate may mediate angiogenesis and fibrous tissue formation (scarring) in injured tendons. Hyperglycemia and high glucose affect matrix metabolism, growth factor production, and glycation end products in tendon cells and progenitors, 23, 24 suggesting that control of glucose utilization, such as control of glucose production/absorption and insulin sensitivity, is important in maintenance or stimulation of tendon cell function and may be a therapeutic target for tendinopathy. 1, 35 Lactate synthesis can be a regulatory point in this scenario.
Mucoid degeneration, accumulation of glycosaminoglycan, is one of the pathologic features of tendinopathy. 18 In this study, DCA treatment strongly reduced accumulation of mucoid materials and inhibited ectopic calcification. Studies demonstrated that ectopic calcification in rodent Achilles tendon rupture models is caused by ectopic chondrogenesis-mediated endochondral ossification. 5, 45 Hypoxia enhances or is associated with chondrogenesis, 20, 37 and an increase in lactate production was observed during chondrogenesis in human mesenchymal stem cell cultures. 33 Thus, inhibition of lactate formation by DCA might suppress initiation or progression of chondrogenesis. It was reported that forced expression of PDK2, an inhibitor of pyruvate dehydrogenase, induced chondrogenesis in human mesenchymal cells in culture via Sox6 and activation of the JNK/MAPK/ERK pathway. 41 Since DCA is an inhibitor of PDKs, 43 our finding is consistent with this report. As an increase in ectopic calcification is associated with decreased mechanical strengths, 49 inhibition of accumulation of glycosaminoglycan and ectopic calcification is likely to be favorable for tendon repair, although we should further define whether such effects directly lead to improvement of mechanical properties in injured tendons.
Our findings suggest that reprogramming of metabolism may be a therapeutic target for tendon repair. Metabolic modifiers for glucose metabolism and lactate transport have been studied in clinical trials for cancer therapy. A similar approach might be applied for improvement of tendon healing.
